Literature DB >> 1318780

Near-haploid clones in a malignant fibrous histiocytoma.

C Orndal1, N Mandahl, B Carlén, H Willén, J Wennerberg, S Heim, F Mitelman.   

Abstract

Near-haploid solid tumors are very rare. In a storiform-pleomorphic malignant fibrous histiocytoma (MFH) of bone, we found three cell populations: one with a near-haploid, a second with a near-diploid, and a third with a near-tetraploid chromosome number. The near-haploid cells had few structural rearrangements: i(12p) and t(13q21q) in one clone, and these two and an additional t(19;?)(p11;?) in another clone. One structurally normal copy of all chromosomes was also present, except that the only chromosome 13 was involved in the t(13q21q). There were also two near-diploid clones, one without the t(19;?) and one with a single copy of this derivative chromosome. This is the first tumor with i(12p) among bone and soft tissue tumors.

Entities:  

Mesh:

Year:  1992        PMID: 1318780     DOI: 10.1016/0165-4608(92)90007-u

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma.

Authors:  J V Bovée; M van Royen; A F Bardoel; C Rosenberg; C J Cornelisse; A M Cleton-Jansen; P C Hogendoorn
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

2.  Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic features.

Authors:  Fredrik Mertens; Salvatore Romeo; Judith Vmg Bovée; Roberto Tirabosco; Nick Athanasou; Marco Alberghini; Pancras Cw Hogendoorn; Angelo P Dei Tos; Raf Sciot; Henryk A Domanski; Kristina Aström; Nils Mandahl; Maria Debiec-Rychter
Journal:  Clin Sarcoma Res       Date:  2011-10-13

3.  Haploid genomes illustrate epigenetic constraints and gene dosage effects in mammals.

Authors:  Martin Leeb; Anton Wutz
Journal:  Epigenetics Chromatin       Date:  2013-12-05       Impact factor: 4.954

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.